Table 2.
NHANES 1999–2006 |
NHANES 1999–2002 |
NHANES 2003–2006 |
||||
---|---|---|---|---|---|---|
% (SE)b | β (SE) | % (SE)b | β (SE) | % (SE)b | β (SE) | |
BLL quartile 1 (≤0.70 μg/dL) | 24.9(0.98) | 0 (reference) | 20.3 (1.02) | 0 (reference) | 29.4 (1.55) | 0 (reference) |
BLL quartile 2 (0.71–1.09 μg/dL) | 24.6 (0.76) | −0.06 (0.04) p = 0.20 |
22.0 (0.96) | 0.01 (0.07) p = 0.95 |
27.1 (1.12) | −0.10 (0.06) p = 0.10 |
BLL quartile 3 (1.10–1.60 μg/dL) | 25.6 (0.61) | −0.15 (0.06) p = 0.01 |
28.7 (0.77) | −0.16 (0.10) p = 0.13 |
22.6 (0.93) | −0.13 (0.07) p = 0.10 |
BLL quartile 4 (≥1.61 μg/dL) | 24.9 (1.02) | −0.33 (0.07) p ≤ 0.01 |
29.0 (1.41) | −0.31 (0.12) p ≤ 0.01 |
20.9 (1.30) | −0.31 (0.08) p ≤ 0.01 |
p trend | p ≤ 0.01 | p = 0.03 | p ≤ 0.01 |
Adjusted for age, gender, race/ethnicity, hematocrit, calorie intake, TV and video game use, serum cotinine, and poverty income ratio.
Percentages are sample-weighted for applicability to the U.S. population.